ABSTRACT
Introduction Hip fracture is a common and serious emergency in the elderly, it is associated with severe pain, significant postoperative morbidity and mortality. Featuring peripheral nerve block in Enhanced recovery after surgery (ERAS) pathway may have significantly effect on shortening length of hospital stay, decreasing complications and costs, particular in improvement in dynamic pain and reducing the use of opioid. Pericapsular Nerve Group Block(PENG), suggested by Arango et al, may provide a effective blockade to the articular branches of the anterior hip joint,which innervate the most section of the hip capsule richly, with a potential motor-sparing effect.The purpose of this trail is to investigate whether PENG is effective to enhanced recovery in elderly patients with hip fracture.
Methods and analysis This study will be a single centre,randomized, parallel controlled, double-blind trail. 92 elderly patients scheduled for hip fracture surgery will be divided into two groups randomly to receive ultrasound-guided PENG block or ultrasound-guided femoral nerve(FN) block. The primary outcome will be compare the quality of recovery-15(QoR-15) score at 24h postoperatively between two groups.The secondary outcomes include the strength of quadriceps, the visual analogue scale(VAS) at rest and on movement, the total morphine consumption, the rescue analgesic, the first time of postoperative out-of-bed mobilization, the complications.
Ethics and dissemination This study has been approved by the Medical Science Research Ethics Committees of The First Affiliated Hospital of Guangzhou University of Chinese Medicine on 15 December 2020 (Reference K2020-110). The results of this study will be published in peer-reviewed international journals.
Trial registration number ChiCTR2100042341.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ChiCTR2100042341
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
the Medical Science Research Ethics Committees of The First Affiliated Hospital of Guangzhou University of Chinese Medicine
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Authors’ email Wei Luo; 179164186{at}qq.com
Quehua Luo; luoquehua{at}163.com
Jieting Wu; 501911806{at}qq.com
Jianhui Liang; Plpatpat{at}qq.com
Huiyi Wu; 591170749{at}qq.com
Yanhua Ou; 197181567{at}qq.com
Yuhui Li; liliuyuhui{at}126.com
Wuhua Ma; tuesdaymorninggz{at}126.com
Data Availability
Demographic data and mental assessment data, QoR-15 data and information on pain scores, mobilization assessment data and complications will be collected and input into an electronic database. An independent researcher will guarantee the data quality during the process. All data of outcomes will be input into another independent data and double-checked to promote the data quality. The individual privacy information will be deleted to protect confidentiality. After data storage, only researchers can access to the final trial dataset directly. The progress and safety of this study will be monitored by the data monitoring committee, which composed of two professors outside the study. The DMC can give suggestions about the safety, and even pause the trial.
